Table 1.
Demographic and Preoperative Ocular Characteristics
| 57 Eyes of 57 Subjects | ||
|---|---|---|
| Gender Male/Female | 30/27 | |
| Race | % Caucasian | 100% (n=57) |
| Age (years) | Mean ± SD | 65.3 ± 9.0 |
| C:D ratio | Mean ± SD | 0.7 ± 0.1 |
| Medicated IOP (mmHg) | Mean ± SD | 19.5 ± 1.5 |
| Preoperative # medications | Mean ± SD | 1 ± 0 |
| Medication classes | % of eyes (n) | |
| Prostaglandin | 86% (n=49) | |
| Beta-blocker | 7% (n=4) | |
| Carbonic anhydrase inhibitor | 7% (n=4) | |
| Unmedicated IOP (mmHg) | Mean ± SD | 24.4 ± 1.3 |
| Glaucoma severity (available in 56 eyes)a | n (%) | |
| Mild | 5 (8.9%) | |
| Moderate | 15 (26.8%) | |
| Severe | 36 (64.3%) | |
Notes: aSeverity according to the Hodapp Parrish Anderson (HPA) glaucoma severity scale (Mild: mean deviation (MD) no worse than −6 dB; Moderate: MD worse than −6 dB but no worse than −12 dB; Severe: MD worse than −12 dB). Adapted from Lindstrom R, Lewis R, Hornbeak DM, et al. Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up. Adv Ther. 2016;33(11):2082-90.36 This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/).